IP Library Granted Patent US 7,927,607
Granted Patent B2
US 7,927,607 · App. 12/203,572 · Granted Apr 19, 2011

Patent

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,927,607
App. No.
12/203,572
Granted
Apr 19, 2011
Kind
B2
Abstract

The present invention discloses isolated nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments thereof from S. agalactiae , and methods for isolating such antigens and specific uses thereof.

Claims (11)

1. An isolated hyperimmune serum reactive antigen fragment consisting of the amino acids: 1-26, 1-47, 4-26, 35-41, 53-61, 73-84, 103-108, 114-120, 115-132, 140-146, 156-162, 192-208, 214-219, 227-233, 239-252, 260-268, 284-297, 1-48 or 113-133 of SEQ ID NO:475.

2. An immunogenic composition comprising an isolated hyperimmune serum-reactive antigen fragment of claim 1 .

3. The immunogenic composition of claim 2 , comprising at least two different isolated hyperimmune serum-reactive antigen fragments.

4. The immunogenic composition of claim 2 , further comprising an immunostimulatory substance.

5. The immunogenic composition of claim 4 , wherein the immunostimulatory substance is a polycationic polymer, an immunostimulatory deoxynucleotide (ODN), a peptide containing at least two LysLeuLys motifs, a neuroactive compound, alum, or a Freund's complete or incomplete adjuvant.

6. The immunogenic composition of claim 5 , wherein the polycationic polymer is a polycationic peptide.

7. The immunogenic composition of claim 5 , wherein the neuroactive compound is human growth hormone.

8. A method of eliciting an immune response in a subject comprising:

obtaining an immunogenic composition of claim 1 ; and administering the immunogenic composition to a subject; wherein an immune response is elicited in the subject.

9. The method of claim 8 , wherein the immune response is directed against S. agalactiae.

10. The method of claim 8 , wherein the immunogenic composition comprises at least two different isolated hyperimmune serum-reactive antigen fragments.

Assignments (3)
CHANGE OF NAME Recorded Dec 17, 2014
From: INTERCELL AUSTRIA AG
To: VALNEVA AUSTRIA GMBH
Reel/Frame 034524/0311 →
ASSET TRANSFER AGREEMENT Recorded Dec 17, 2014
From: INTERCELL AG
To: INTERCELL AUSTRIA AG
Reel/Frame 034659/0640 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2011
From: MEINKE, ANDREAS; NAGY, ESZTER; HANNER, MARKUS; HORKY, MARKUS; KALLENDA, SABINE; PRUSTOMERSKY, SONJA
To: INTERCELL AG
Reel/Frame 026323/0968 →